An ongoing project on phosphopeptide microarray analysis of human ventricular cardiomyocytes treated with various cancer drugs to simulate a chemotherapy induced cardiotoxicity response revealed time-dose dependent upregulation and down regulation of endogenous phosphoprotein-GRB2 interactions (Krishnamoorthy and Gao unpublished). This evidence concerns the gene GRB2 and cancer.